Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 12, 2025

Total Value ($000): $281,835 (100.0% shares, 0.0% debt)

Holdings (15)

BBIO BridgeBio Pharma Inc. (BBIO) 59.1%

Value ($000) $166,509 Shares 6,068,125 Est. Cost $40.43 Unrealized -36.1%

— Verona Pharma plc (VRNA) 18.4%

Value ($000) $51,797 Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 4.8%

Value ($000) $13,551 Shares 1,025,000 Est. Cost $10.24 Unrealized +67.1%

GLUE Monte Rosa Therapeutics Inc (GLUE) 3.6%

Value ($000) $10,218 Shares 1,472,331 Est. Cost $20.37 Unrealized -63.2%

— Poseida Therapeutics Inc. (PSTX) 3.6%

Value ($000) $10,015 Shares 1,043,267 Est. Cost $8.87 Unrealized —

BCAX Bicara Therapeutics Inc. (BCAX) 3.5%

Value ($000) $9,911 Shares 568,919 Est. Cost $25.50 Unrealized -18.4%

NUVB Nuvation Bio Inc. (NUVB) 2.4%

Value ($000) $6,759 Shares 2,541,009 Est. Cost $11.18 Unrealized -77.0%

CMPS Compass Pathways Plc (CMPS) 1.3%

Value ($000) $3,646 Shares 964,500 Est. Cost $7.40 Unrealized —

BMEA Biomea Fusion Inc (BMEA) 1.1%

Value ($000) $3,099 Shares 798,757 Est. Cost $17.65 Unrealized -54.9%

CALC CalciMedica, Inc. (CALC) 0.7%

Value ($000) $1,845 Shares 521,114 Est. Cost $4.55 Unrealized -22.9%

— Elevation Oncology Inc (ELEV) 0.6%

Value ($000) $1,588 Shares 2,834,910 Est. Cost $13.57 Unrealized —

ACRS Aclaris Therapeutics Inc (ACRS) 0.4%

Value ($000) $1,077 Shares 434,455 Est. Cost $10.31 Unrealized -75.9%

MRKR Marker Therapeutics, Inc. (MRKR) 0.4%

Value ($000) $1,012 Shares 325,370 Est. Cost $1.80 Unrealized +96.8%

OKUR OnKure Therapeutics, Inc. (OKUR) 0.3%

Value ($000) $762 Shares 88,607 Est. Cost $15.14 Unrealized 0.0%

— Viracta Therapeutics Inc (VIRX) 0.0%

Value ($000) $46 Shares 288,571 Est. Cost $11.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$166,509	59.1%	$40.43	-36.1%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,115,352	$51,797	18.4%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$13,551	4.8%	$10.24	+67.1%	COM	87164F105
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$10,218	3.6%	$20.37	-63.2%	COM	61225M102
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$10,015	3.6%	$8.87	—	COM	73730P108
BCAX	Bicara Therapeutics Inc. (BCAX)	568,919	$9,911	3.5%	$25.50	-18.4%	COM	055477103
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$6,759	2.4%	$11.18	-77.0%	COM CL A	67080N101
CMPS	Compass Pathways Plc (CMPS)	964,500	$3,646	1.3%	$7.40	—	SPONSORED ADS	20451W101
BMEA	Biomea Fusion Inc (BMEA)	798,757	$3,099	1.1%	$17.65	-54.9%	COM	09077A106
CALC	CalciMedica, Inc. (CALC)	521,114	$1,845	0.7%	$4.55	-22.9%	COM NEW	38942Q202
—	Elevation Oncology Inc (ELEV)	2,834,910	$1,588	0.6%	$13.57	—	COM	28623U101
ACRS	Aclaris Therapeutics Inc (ACRS)	434,455	$1,077	0.4%	$10.31	-75.9%	COM	00461U105
MRKR	Marker Therapeutics, Inc. (MRKR)	325,370	$1,012	0.4%	$1.80	+96.8%	COM NEW	57055L206
OKUR	OnKure Therapeutics, Inc. (OKUR)	88,607	$762	0.3%	$15.14	0.0%	COM CL A	68277Q105
—	Viracta Therapeutics Inc (VIRX)	288,571	$46	0.0%	$11.34	—	COM	92765F108